封面
市場調查報告書
商品編碼
1553431

首頁 睡眠呼吸中止症測試市場規模、佔有率、趨勢分析報告:按地區、細分市場預測,2024-2030 年

Home Sleep Apnea Test Market Size, Share & Trends Analysis Report By Region (North America, Asia Pacific, Europe, Latin America, Middle East & Africa), And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

家庭睡眠呼吸中止症測試市場的成長與趨勢:

Grand View Research, Inc.最新報告顯示,預計2030年全球家庭睡眠呼吸中止症檢測市場規模將達33.8億美元,2024年至2030年複合年成長率為6.4%。

市場成長是由知名公司不斷增加投資推動的,這些投資旨在推動家庭睡眠呼吸中止症測試 (HSAT) 的技術進步。例如,2024年3月,倍靈科技有限公司啟動了評估倍靈環平台的臨床試驗。 Belun Ring 是一種穿戴式技術,採用人工智慧 (AI) 協助醫療專業人員診斷阻塞型睡眠呼吸中止症(OSA) 並對睡眠階段進行分類。對於家用睡眠評估,請使用這種環形設備,該設備具有內建脈動式血氧監測儀系統和加速計,並佩戴在近端食指上。

此外,睡眠呼吸中止症的盛行率不斷上升,以及旨在提高人們對治療睡眠呼吸中止症的技術先進解決方案的認知的舉措不斷增多,也推動了市場的成長。根據美國國家老化委員會 2024 年 5 月發布的資料,大約有 600 萬美國被正式診斷出患有睡眠呼吸暫停,但這種情況估計影響了美國 3,000 萬人。睡眠呼吸中止症的盛行率往往會隨著年齡的成長而增加,研究顯示 65 歲以上的成年人患阻塞型睡眠呼吸中止症的風險增加 56%。

COVID-19 透過鼓勵最終用戶採用遠端醫療解決方案對市場產生了積極影響。根據 Itamar Medical 與 Sleep Medicine Publication 合作進行的 2021 年 3 月調查顯示,29% 的睡眠診所優先考慮實驗室測試而不是家用解決方案,而且這一比例預計會進一步下降。這一轉變得到了一次性家庭睡眠呼吸中止測試 (HSAT) 的採用的支持,該測試不需要退貨運輸或設備隔離。居家呼吸暫停測試提供即時結果的能力增強,進一步減少了對傳統實驗室測試指導患者從初始篩檢到診斷和治療的依賴。在大流行期間,67% 的診所報告說,實驗室中的患者檢測數量中度至顯著減少,而 66% 的診所則指出,家庭睡眠呼吸中止症檢測的使用量也出現了類似的增加。 65% 的診所預測這一趨勢將在新冠疫情後持續下去,他們更傾向於將 HSAT 作為睡眠呼吸中止症的主要診斷工具。

此外,市場主要企業正在採取併購、合作、聯盟、業務擴張和新產品發布等各種策略,以滿足最終用戶不斷變化的需求並鞏固其市場地位。例如,2023 年 3 月,英國醫療技術公司 Acurable 在美國推出了用於阻塞型睡眠呼吸中止症診斷的 AcuPebble 設備,繼最近獲得 FDA核准後擴大了其市場範圍。該設備於 2021 年首次在歐洲推出,增強了偏遠地區的家庭睡眠呼吸中止症測試能力,有助於更快診斷、加速治療和更好地管理病情。

首頁 睡眠呼吸中止測試市場報告亮點

  • 2023 年,北美市場佔有率最大,達 47.74%。呼吸系統疾病盛行率上升、阻塞型睡眠呼吸中止症(OSA)意識增強以及支持市場成長的政府支持政策推動了市場成長。
  • 預計2024年至2030年,亞太市場將以8.0%的複合年成長率成長最快。這一成長歸功於該地區大量採用技術先進的 HSAT。
  • 主要企業正在採取各種策略,例如產品發布、聯盟、收購和合併,以擴大其服務組合併加強其地理影響力,從而導致市場內的激烈競爭。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 家庭睡眠呼吸中止症測試市場變數、趨勢與範圍

  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
  • 家用睡眠呼吸中止症測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章 家庭睡眠呼吸中止症測試市場:區域估計和趨勢分析,按產品、按應用、按最終用途

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析:
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第5章競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率/地位分析
  • 公司簡介
    • Resmed
    • Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation(a ASAHI KASEI company)
    • Cleveland Medical Devices Inc.
    • Compumedics Limited
    • Onera Technologies BV
    • Sunrise
    • Nox Medical
    • Watermark Medical
    • Bittium
    • Cadwell Industries Inc.
Product Code: GVR-4-68040-412-3

Home Sleep Apnea Test Market Growth & Trends:

The global home sleep apnea test market size is expected to reach USD 3.38 billion by 2030, growing at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to the increasing investment by prominent players, aimed at technological advancements in the home sleep apnea tests (HSAT). For instance, in March 2024, Belun Technology Company Ltd. launched a clinical trial aimed at the evaluation of the Belun Ring platform. The Belun Ring, a wearable technology, employs Artificial Intelligence (AI) to assist medical professionals in diagnosing Obstructive Sleep Apnea (OSA) and categorizing sleep phases. For home sleep assessments, individuals use this ring device, which incorporates a pulse oximeter and an accelerometer and is worn on the proximal index finger.

Moreover, the increasing prevalence of sleep apnea coupled with growing initiatives aimed at increasing awareness regarding the availability of technologically advanced solutions to treat sleep apnea is also contributing to the market growth. According to data published by the National Council on Aging, Inc. in May 2024 showcases that approximately 6 million Americans are formally diagnosed with sleep apnea; however, the condition is estimated to impact 30 million people within the U.S. The prevalence of sleep apnea tends to increase with age, the studies indicate that adults aged 65 and above exhibit a 56% higher risk of developing obstructive sleep apnea.

COVID-19 positively impacted the market as it forced the end users to adopt remote medical solutions. According to a survey conducted by Itamar Medical in partnership with Sleep Medicine Publication in March 2021 showcased that 29% of sleep clinics prioritize in-lab studies over at-home solutions-a proportion anticipated to decline further. This shift is supported by the adoption of disposable Home Sleep Apnea Tests (HSATs), which prevent the need for return shipping or equipment quarantine. Enhanced capabilities of home-based apnea tests, delivering instant results, further reduce the dependency on traditional in-lab studies for patient progression from initial screening through to diagnosis and treatment. During the pandemic, 67% of the clinics reported a moderate to significant reduction in in-lab patient studies, whereas 66% noted a comparable increase in the utilization of home sleep apnea tests. A substantial 65% of clinics foresee the continuation of this trend post-COVID, with a preference for HSATs as the primary diagnostic tool for sleep apnea.

Furthermore, key players in the market are adopting various strategies such as mergers & acquisitions, partnerships, collaborations, expansions, and new product launches to cater to the evolving demand of end users and strengthen their market positions. For instance, in March 2023, UK-based medical technology firm Acurable expanded its market reach by launching the AcuPebble device for the diagnosis of obstructive sleep apnea in the U.S. following recent FDA approval. Initially introduced in Europe in 2021, this device enhances the capability for remote, home-based sleep apnea testing, facilitating prompt diagnosis, accelerated treatment, and improved management of the condition.

Home Sleep Apnea Test Market Report Highlights:

  • North America held the largest market share of 47.74% in 2023. The market growth is attributed to a rising incidence of respiratory conditions, enhanced recognition of Obstructive Sleep Apnea (OSA), and supportive government policies that are fueling the market growth.
  • The market in Asia Pacific is expected to register the fastest growth rate at a CAGR of 8.0% from 2024 to 2030. The growth is attributed to the significant adoption of technologically advanced HSATs in the region.
  • Major players are employing various strategies such as product launches, collaborations, acquisitions, and mergers to expand their service portfolios and enhance their geographical presence, leading to significant competition within the market.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Home Sleep Apnea Test Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunity Analysis
  • 3.2. Home Sleep Apnea Test Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis

Chapter 4. Home Sleep Apnea Test Market: Regional Estimates & Trend Analysis, By Product, By Application, By End Use

  • 4.1. Regional Market Share Analysis, 2023 & 2030
  • 4.2. Regional Market Dashboard
  • 4.3. Global Regional Market Snapshot
  • 4.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 4.5. North America
    • 4.5.1. U.S.
      • 4.5.1.1. Key country dynamics
      • 4.5.1.2. Regulatory framework/ reimbursement structure
      • 4.5.1.3. Competitive scenario
      • 4.5.1.4. U.S. market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.2. Canada
      • 4.5.2.1. Key country dynamics
      • 4.5.2.2. Regulatory framework/ reimbursement structure
      • 4.5.2.3. Competitive scenario
      • 4.5.2.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.5.3. Mexico
      • 4.5.3.1. Key country dynamics
      • 4.5.3.2. Regulatory framework/ reimbursement structure
      • 4.5.3.3. Competitive scenario
      • 4.5.3.4. Canada market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.6. Europe
    • 4.6.1. UK
      • 4.6.1.1. Key country dynamics
      • 4.6.1.2. Regulatory framework/ reimbursement structure
      • 4.6.1.3. Competitive scenario
      • 4.6.1.4. UK market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.2. Germany
      • 4.6.2.1. Key country dynamics
      • 4.6.2.2. Regulatory framework/ reimbursement structure
      • 4.6.2.3. Competitive scenario
      • 4.6.2.4. Germany market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.3. France
      • 4.6.3.1. Key country dynamics
      • 4.6.3.2. Regulatory framework/ reimbursement structure
      • 4.6.3.3. Competitive scenario
      • 4.6.3.4. France market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.4. Italy
      • 4.6.4.1. Key country dynamics
      • 4.6.4.2. Regulatory framework/ reimbursement structure
      • 4.6.4.3. Competitive scenario
      • 4.6.4.4. Italy market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.5. Spain
      • 4.6.5.1. Key country dynamics
      • 4.6.5.2. Regulatory framework/ reimbursement structure
      • 4.6.5.3. Competitive scenario
      • 4.6.5.4. Spain market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.6. Norway
      • 4.6.6.1. Key country dynamics
      • 4.6.6.2. Regulatory framework/ reimbursement structure
      • 4.6.6.3. Competitive scenario
      • 4.6.6.4. Norway market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.7. Sweden
      • 4.6.7.1. Key country dynamics
      • 4.6.7.2. Regulatory framework/ reimbursement structure
      • 4.6.7.3. Competitive scenario
      • 4.6.7.4. Sweden market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.6.8. Denmark
      • 4.6.8.1. Key country dynamics
      • 4.6.8.2. Regulatory framework/ reimbursement structure
      • 4.6.8.3. Competitive scenario
      • 4.6.8.4. Denmark market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.7. Asia Pacific
    • 4.7.1. Japan
      • 4.7.1.1. Key country dynamics
      • 4.7.1.2. Regulatory framework/ reimbursement structure
      • 4.7.1.3. Competitive scenario
      • 4.7.1.4. Japan market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.2. China
      • 4.7.2.1. Key country dynamics
      • 4.7.2.2. Regulatory framework/ reimbursement structure
      • 4.7.2.3. Competitive scenario
      • 4.7.2.4. China market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.3. India
      • 4.7.3.1. Key country dynamics
      • 4.7.3.2. Regulatory framework/ reimbursement structure
      • 4.7.3.3. Competitive scenario
      • 4.7.3.4. India market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.4. Australia
      • 4.7.4.1. Key country dynamics
      • 4.7.4.2. Regulatory framework/ reimbursement structure
      • 4.7.4.3. Competitive scenario
      • 4.7.4.4. Australia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.5. South Korea
      • 4.7.5.1. Key country dynamics
      • 4.7.5.2. Regulatory framework/ reimbursement structure
      • 4.7.5.3. Competitive scenario
      • 4.7.5.4. South Korea market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.7.6. Thailand
      • 4.7.6.1. Key country dynamics
      • 4.7.6.2. Regulatory framework/ reimbursement structure
      • 4.7.6.3. Competitive scenario
      • 4.7.6.4. Singapore market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.8. Latin America
    • 4.8.1. Brazil
      • 4.8.1.1. Key country dynamics
      • 4.8.1.2. Regulatory framework/ reimbursement structure
      • 4.8.1.3. Competitive scenario
      • 4.8.1.4. Brazil market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.8.2. Argentina
      • 4.8.2.1. Key country dynamics
      • 4.8.2.2. Regulatory framework/ reimbursement structure
      • 4.8.2.3. Competitive scenario
      • 4.8.2.4. Argentina market estimates and forecasts 2018 to 2030, (USD Billion)
  • 4.9. MEA
    • 4.9.1. South Africa
      • 4.9.1.1. Key country dynamics
      • 4.9.1.2. Regulatory framework/ reimbursement structure
      • 4.9.1.3. Competitive scenario
      • 4.9.1.4. South Africa market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.2. Saudi Arabia
      • 4.9.2.1. Key country dynamics
      • 4.9.2.2. Regulatory framework/ reimbursement structure
      • 4.9.2.3. Competitive scenario
      • 4.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.3. UAE
      • 4.9.3.1. Key country dynamics
      • 4.9.3.2. Regulatory framework/ reimbursement structure
      • 4.9.3.3. Competitive scenario
      • 4.9.3.4. UAE market estimates and forecasts 2018 to 2030, (USD Billion)
    • 4.9.4. Kuwait
      • 4.9.4.1. Key country dynamics
      • 4.9.4.2. Regulatory framework/ reimbursement structure
      • 4.9.4.3. Competitive scenario
      • 4.9.4.4. Kuwait market estimates and forecasts 2018 to 2030, (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Key company market share/position analysis, 2023
  • 5.4. Company Profiles
    • 5.4.1. Resmed
      • 5.4.1.1. Company overview
      • 5.4.1.2. Financial performance
      • 5.4.1.3. Product benchmarking
      • 5.4.1.4. Strategic initiatives
    • 5.4.2. Itamar Medical Ltd a subsidiary of ZOLL Medical Corporation ( a ASAHI KASEI company)
      • 5.4.2.1. Company overview
      • 5.4.2.2. Financial performance
      • 5.4.2.3. Product benchmarking
      • 5.4.2.4. Strategic initiatives
    • 5.4.3. Cleveland Medical Devices Inc.
      • 5.4.3.1. Company overview
      • 5.4.3.2. Financial performance
      • 5.4.3.3. Product benchmarking
      • 5.4.3.4. Strategic initiatives
    • 5.4.4. Compumedics Limited
      • 5.4.4.1. Company overview
      • 5.4.4.2. Financial performance
      • 5.4.4.3. Product benchmarking
      • 5.4.4.4. Strategic initiatives
    • 5.4.5. Onera Technologies B.V.
      • 5.4.5.1. Company overview
      • 5.4.5.2. Financial performance
      • 5.4.5.3. Product benchmarking
      • 5.4.5.4. Strategic initiatives
    • 5.4.6. Sunrise
      • 5.4.6.1. Company overview
      • 5.4.6.2. Financial performance
      • 5.4.6.3. Product benchmarking
      • 5.4.6.4. Strategic initiatives
    • 5.4.7. Nox Medical
      • 5.4.7.1. Company overview
      • 5.4.7.2. Financial performance
      • 5.4.7.3. Product benchmarking
      • 5.4.7.4. Strategic initiatives
    • 5.4.8. Watermark Medical
      • 5.4.8.1. Company overview
      • 5.4.8.2. Financial performance
      • 5.4.8.3. Product benchmarking
      • 5.4.8.4. Strategic initiatives
    • 5.4.9. Bittium
      • 5.4.9.1. Company overview
      • 5.4.9.2. Financial performance
      • 5.4.9.3. Product benchmarking
      • 5.4.9.4. Strategic initiatives
    • 5.4.10. Cadwell Industries Inc.
      • 5.4.10.1. Company overview
      • 5.4.10.2. Financial performance
      • 5.4.10.3. Product benchmarking
      • 5.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 3 U.S. Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 4 Canada Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 5 Mexico Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 6 Europe Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 7 Germany Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 8 UK Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 9 France Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 10 Italy Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 11 Spain Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 12 Denmark Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 13 Sweden Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 14 Norway Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 15 Asia Pacific Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 16 China Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 17 Japan Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 18 India Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 19 South Korea Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 20 Australia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 21 Thailand Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 22 Latin America Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 23 Brazil Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 24 Argentina Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 25 MEA Home Sleep Apnea Test Market, by region, (USD Billion) 2018 - 2030
  • Table 26 South Africa Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 27 Saudi Arabia Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 28 UAE Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030
  • Table 29 Kuwait Home Sleep Apnea Test Market, (USD Billion) 2018 - 2030

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Home Sleep Apnea Test Market outlook
  • Fig. 9 Home sleep apnea test competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Home Sleep Apnea Test Market driver impact
  • Fig. 15 Home Sleep Apnea Test Market restraint impact
  • Fig. 16 Home Sleep Apnea Test Market strategic initiatives analysis
  • Fig. 17 Global Home Sleep Apnea Test Market: Regional movement analysis
  • Fig. 18 Global Home Sleep Apnea Test Market: Regional outlook and key takeaways
  • Fig. 19 Global Home Sleep Apnea Test Market share and leading players
  • Fig. 20 North America market share and leading players
  • Fig. 21 Europe market share and leading players
  • Fig. 22 Asia Pacific market share and leading players
  • Fig. 23 Latin America market share and leading players
  • Fig. 24 Middle East & Africa market share and leading players
  • Fig. 25 North America: SWOT
  • Fig. 26 Europe SWOT
  • Fig. 27 Asia Pacific SWOT
  • Fig. 28 Latin America SWOT
  • Fig. 29 MEA SWOT
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 37 France market estimates and forecasts, 2018 - 2030
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 46 India market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 58 Market share of key market players- Home Sleep Apnea Test Market
  • Fig. 59 Key Company Categorization
  • Fig. 60 Company Market Share/Position Analysis, 2023
  • Fig. 61 Strategic Framework